Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Mar 06 2023
Business
Mar 6 2023
5 min read

Press Release Mar 06 2023

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 06, 2023, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial".

View Attachment